The association between obesity factor and esophageal caner

scientific article

The association between obesity factor and esophageal caner is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3978/J.ISSN.2078-6891.2012.026
P932PMC publication ID3418533
P698PubMed publication ID22943013
P5875ResearchGate publication ID230784852

P2093author name stringQi Chen
Yanhui Liu
Hengguo Zhuang
P2860cites workCancer incidence and mortality in relation to body mass index in the Million Women Study: cohort studyQ24684767
Global cancer statistics, 2002Q27860562
Cancer statistics, 2012Q27860574
Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsQ28131763
Obesity: preventing and managing the global epidemic. Report of a WHO consultationQ29547404
Prevalence and trends in obesity among US adults, 1999-2008Q29547759
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesQ29614869
Body-mass index and symptoms of gastroesophageal reflux in womenQ33245320
A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequenceQ34022123
Plasma insulin-like growth factor-I and prostate cancer risk: a prospective studyQ34065827
Influence of obesity on the risk of esophageal disordersQ34190035
Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort studyQ34576888
Central adiposity and risk of Barrett's esophagusQ34660127
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardiaQ34744904
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complicationsQ36215395
Helicobacter pylori and esophageal cancer risk: a meta-analysisQ36410246
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysisQ36479652
A prospective study of BMI and risk of oesophageal and gastric adenocarcinomaQ36597089
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age.Q36841557
Abdominal obesity and the risk of esophageal and gastric cardia carcinomasQ37163349
Trends in esophageal cancer and body mass index by race and gender in the state of Michigan.Q37255726
Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpressionQ37305467
Adiponectin action from head to toe.Q37801870
Continuing rapid increase in esophageal adenocarcinoma in England and WalesQ39171596
Associations between leptin and adiponectin receptor upregulation, visceral obesity and tumour stage in oesophageal and junctional adenocarcinomaQ39679982
Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptorQ39921074
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.Q40817530
Trends in incidence rates of adenocarcinoma of the oesophagus and gastric cardia in New Zealand, 1978-1992.Q41215729
Endoscopic sonography in esophageal cancerQ42146707
Cyclic estradiol treatment normalizes body weight and restores physiological patterns of spontaneous feeding and sexual receptivity in ovariectomized ratsQ44253219
Adenocarcinoma of the esophagus: role of obesity and dietQ44476677
Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control studyQ46538261
Adiponectin multimeric complexes and the metabolic syndrome trait clusterQ46870222
Body size and composition and the risk of gastric and oesophageal adenocarcinomaQ47357608
Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and womenQ47405537
Gonadal hormones determine sensitivity to central leptin and insulinQ48603194
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma.Q49304505
Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.Q50537419
Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus.Q50661717
Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients.Q50859761
Age effects and temporal trends in adenocarcinoma of the esophagus and gastric cardia (United States).Q51937686
Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets.Q53255823
Relation of body mass index to cancer risk in 362,552 Swedish men.Q53343955
Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.Q53387945
Adenocarcinoma of the oesophagus and gastric cardia: Male preponderance in association with obesityQ57521964
Circulating concentrations of insulin-like growth factor I and risk of breast cancerQ57751183
Association between body mass and adenocarcinoma of the esophagus and gastric cardiaQ58204836
Leptin binding activity changes with age: the link between leptin and pubertyQ62750339
Serum leptin levels during the menstrual cycle of healthy fertile womenQ73009037
Demographic variations in the rising incidence of esophageal adenocarcinoma in white malesQ74373937
Estrogen deficiency causes central leptin insensitivity and increased hypothalamic neuropeptide YQ77378685
Precedence of the shift of body-fat distribution over the change in body composition after menopauseQ80291217
Obesity and lifestyle risk factors for gastroesophageal reflux disease, Barrett esophagus and esophageal adenocarcinomaQ80291239
The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidenceQ81290009
A polymorphic variant of the insulin-like growth factor type I receptor gene modifies risk of obesity for esophageal adenocarcinomaQ84398648
P433issue3
P921main subjectobesityQ12174
P304page(s)226-231
P577publication date2012-09-01
P1433published inJournal of gastrointestinal oncologyQ26842467
P1476titleThe association between obesity factor and esophageal caner
P478volume3

Reverse relations

cites work (P2860)
Q34595624AZD5363 Inhibits Inflammatory Synergy between Interleukin-17 and Insulin/Insulin-Like Growth Factor 1
Q92756427Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients
Q26852690Epidemiological studies of esophageal cancer in the era of genome-wide association studies
Q33849679HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Q36719828Influence of reflux and central obesity on intercellular space diameter of esophageal squamous epithelium
Q36463755Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex.
Q36162507Pathologic aspects of tumors of gastrointestinal tract in the era of personalized medicine
Q38674291Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.
Q37061705Sedation Challenges: Obesity and Sleep Apnea

Search more.